ArticlemAbs

Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development.

Rosalynn Molden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.